Clinical Trials Browser

INDUSTRY × balstilimab × Tumor-Agnostic × Clear all

NCT05572970 2026-05-06

Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884)

Neoplasms

NCT04156100 2022-03-03

A Study in Subjects With Advanced Solid Tumors

Phase 1 Terminated

Neoplasms